Z79.62

Long term (current) use of immunosuppressive biologic

Long term (current) use of calcineurin inhibitor

Long term (current) use of Janus kinase inhibitor

Long term (current) use of mammalian target of rapamycin (mTOR) inhibitor

Long term (current) use of inhibitors of nucleotide synthesis

Long term (current) use of unspecified immunomodulators and immunosuppressants

Long term (current) use of immunomodulator

Long term (current) use of chemotherapeutic agent

Long term (current) use of myelosuppressive agent

Long term (current) use of other immunomodulators and immunosuppressants